FDA inspection
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC: FDA inspection ending Oct 8, 1999
FDA inspection 42460 · Official Action Indicated (OAI) · Andover, MA
Key facts
| Inspection ID | 42460 |
|---|---|
| Firm | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC |
| FEI number | 1222181 |
| Address | 1 Burtt Rd |
| City | Andover |
| State | MA |
| ZIP | 01810-5901 |
| Fiscal year | 2000 |
| Inspection end date | Oct 8, 1999 |
| Classification | Official Action Indicated (OAI) |
| Project area | Human Cellular, Tissue and Gene Therapies |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data